Time Costs and Out-of-Pocket Costs in Patients With Chronic Hepatitis C in a Publicly Funded Health System-Reference-Cited by-同舟云学术

Time Costs and Out-of-Pocket Costs in Patients With Chronic Hepatitis C in a Publicly Funded Health System

Published:2022-02 Issue:2 Volume:25 Page:247-256
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Wong William W.L.,Wong Josephine,Bremner Karen E.,Saeed Yasmin,Mason Kate,Phoon Arcturus,Feng Zeny,Feld Jordan J.,Mitsakakis Nicholas,Powis Jeff,Krahn Murray

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference42 articles.

1. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes;Petruzziello;World J Gastroenterol,2016

2. Course and outcome of hepatitis C;Hoofnagle;Hepatology,2002

3. Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany;Dintsios;Eur J Gastroenterol Hepatol,2010

4. Management of chronic hepatitis C: consensus guidelines;Sherman;Can J Gastroenterol,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study;Canadian Liver Journal;2023-07-26

2. Pharmacist-led drug therapy management for hepatitis C at a federally qualified health care center;Journal of the American Pharmacists Association;2022-09

3. Patients with chronic hepatitis C have high out-of-pocket costs in Canada;PharmacoEconomics & Outcomes News;2021-10